ROCKET PHARMACEUTICALS, INC.

RCKT · Nasdaq · SIC 2834: Pharmaceutical Preparations
234
SEC Filings

Business Summary

9 Item 1A. Risk Factors 37 Item 1B. Unresolved SEC Comments 64 Item 1C. Cybersecurity 64 Item 2. Properties 65 Item 3. Legal Proceedings 65 Item 4. Mine Safety Disclosures 66 PART II. Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 67 Item 6. Reserved 67 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 67 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 76 Item 8. Fi...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRCKTdiscussed_in_filing Cybersecurity
topic_mentionRCKTdiscussed_in_filing Cybersecurity
topic_mentionRCKTdiscussed_in_filing Cybersecurity
topic_mentionRCKTdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076551EDGAR79K words
2025-02-272024-12-310000950170-25-029002EDGAR—
2024-02-272023-12-310000950170-24-021096EDGAR—
2023-02-282022-12-310001140361-23-009252EDGAR—
2022-02-282021-12-310001140361-22-007036EDGAR—
2021-03-012020-12-310001140361-21-006677EDGAR—
2020-03-062019-12-310001140361-20-005056EDGAR—
2019-03-082018-12-310001140361-19-004603EDGAR—
2018-03-072017-12-310001564590-18-004621EDGAR—
2017-03-162016-12-310001564590-17-004532EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269474EDGAR29K words
2025-08-072025-06-300000950170-25-104996EDGAR—
2025-05-082025-03-310000950170-25-066898EDGAR—
2024-11-072024-09-300000950170-24-123459EDGAR—
2024-08-062024-06-300000950170-24-091838EDGAR—
2024-05-072024-03-310000950170-24-054465EDGAR—
2023-11-072023-09-300000950170-23-060339EDGAR—
2023-08-092023-06-300001140361-23-038855EDGAR—
2023-05-052023-03-310001140361-23-023233EDGAR—
2022-11-042022-09-300001140361-22-040004EDGAR—
2022-08-092022-06-300001140361-22-028904EDGAR—
2022-05-062022-03-310001140361-22-018101EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001140361-26-011573EDGAR2K words
2026-03-100001140361-26-008853EDGAR—
2026-02-260001140361-26-006981EDGAR—
2025-11-060001140361-25-040774EDGAR—
2025-10-140001140361-25-038030EDGAR—
2025-10-030001140361-25-037237EDGAR—
2025-10-030001140361-25-037163EDGAR—
2025-09-290001140361-25-036556EDGAR—
2025-09-170001140361-25-035251EDGAR—
2025-08-250001140361-25-032502EDGAR—

234 total filings indexed. 202 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001281895
TickerRCKT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 92c004a68bb1f9e8e85277283fe8320c40738cbf78911c321f8d5cf0ff3b49eb
parent: 3ffc9cab931134503ed789b64cb28334b57fccb5886118e6c0712bc0fe6bc0e1
content hash: 88bc9ac88f0536c8fde95093b6666485613c17dbee1d6697ecfe3fbc4af7d0e7
signed: 2026-04-13T04:47:08.104Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf